Skip to main content

Medicare Advantage Insurers Face DOJ Lawsuit for Broker Incentive Schemes

by Lawrence J. Tjan | May 02, 2025
A person reviewing insurance plans on a laptop while filling out paperwork at a table with a bowl and calculator.
Photo Source: Adobe Stock Images by Rawpixel.com

The U.S. Department of Justice has filed a lawsuit against major Medicare insurers—Aetna, Elevance Health, and Humana—accusing them of paying kickbacks to brokers in exchange for steering enrollments into their Medicare Advantage plans. According to the complaint, filed in federal court, these insurers paid hundreds of millions of dollars to brokers, undermining the integrity of advice provided to Medicare beneficiaries.

Prosecutors also allege that Aetna and Humana went further, employing these financial incentives to deliberately limit the enrollment of beneficiaries with disabilities, whom the companies viewed as less profitable due to higher medical costs. The complaint specifically names prominent brokers eHealth, GoHealth, and SelectQuote, claiming the illicit activities spanned from 2016 through at least 2021.

Medicare Advantage, managed by private insurers, serves older and disabled Americans. The Justice Department’s lawsuit highlights that brokers are expected to provide impartial advice, yet allegedly favored insurers offering the highest payments, regardless of plan quality. The federal complaint includes internal communications revealing blunt discussions among executives and brokers about financial incentives and discriminatory practices.

In one cited example, a broker described Aetna’s offering in disparaging terms yet emphasized that higher payments would drive increased sales. Another instance documented an Aetna executive openly criticizing brokers for enrolling too many younger, disabled Medicare beneficiaries, actions explicitly labeled as compliance risks in internal discussions.

Humana is similarly accused of pressuring brokers to reduce the proportion of enrollees with disabilities by manipulating marketing tactics, selectively rejecting leads, and filtering incoming inquiries. Brokers faced potential payment reductions from Humana if their enrollments included too high a percentage of beneficiaries with disabilities.

All insurers and brokers named in the complaint have firmly denied wrongdoing. CVS Health, Humana, Elevance Health, eHealth, GoHealth, and SelectQuote have each declared intentions to vigorously defend against the lawsuit, labeling the allegations as baseless or unfounded.

This lawsuit emerges amid heightened scrutiny of Medicare Advantage insurers by federal regulators, partly spurred by investigative reporting by The Wall Street Journal. The Journal previously exposed similar questionable practices in the industry, including strategies employed by UnitedHealth Group to maximize government reimbursements based on inflated patient diagnoses. Newly appointed Medicare chief Mehmet Oz has vowed to tackle questionable industry practices, emphasizing accountability and transparency.

The litigation was initiated following a whistleblower complaint filed by a former employee of broker eHealth.

Share This Article

If you found this article insightful, consider sharing it with your network.

Lawrence J. Tjan
Lawrence is an attorney and CEO of Law Commentary. His legal background includes corporate and general business law, litigation, transactional matters, and law practice management. His litigation experience has included complex matters involving antitrust, insurance bad faith, and medical malpractice. On the transactional side, Lawrence has worked with buy-sell agreements, Regulation D disclosures, stock option plans, and business matters. Lawrence draws on his legal and business experience to help make court decisions, litigation, legislation, public policy, and other legal developments more accessible to the general public and to give readers clear context for understanding the law and how it affects businesses, consumers, and communities.

Related Articles

Gloved medical professional holds an intravenous drug infusion bag in a clinical setting.

Drugmakers Sue to Block Trump Medicare Plan Tying Drug Costs to Lower Foreign Prices

The pharmaceutical industry’s leading trade group is suing the Trump administration over a new Medicare drug-pricing program that could lower out-of-pocket costs for some patients receiving expensive cancer, autoimmune, and other medications administered in medical settings.The Pharmaceutical Research and Manufacturers of America, or PhRMA, filed the lawsuit on October 7,... Read More about Drugmakers Sue to Block Trump Medicare Plan Tying Drug Costs to Lower Foreign Prices

Front view of a UnitedHealthcare office building with a sign displaying the UnitedHealthcare logo in a landscaped area.

Massachusetts Sues UnitedHealthcare Over Alleged $100 Million MassHealth Billing Fraud

Massachusetts Attorney General Andrea Joy Campbell has sued UnitedHealthcare Insurance Company, accusing the insurer of receiving more than $100 million in improper MassHealth payments by allegedly overstating the care needs of seniors enrolled in a Medicaid managed-care program.The complaint, filed May 29 in Suffolk County Superior Court, claims UnitedHealthcare, doing... Read More about Massachusetts Sues UnitedHealthcare Over Alleged $100 Million MassHealth Billing Fraud

Building with the Novartis logo, highlighting the pharmaceutical company's recent legal issues.

Inspector General Issues Fraud Alert Regarding Doctors Paid to Promote Products

The Office of Inspector General for the United States Department of Health and Human Services announced a special fraud alert last month. Special fraud alerts serve as a warning on particular practices that the agency plans on investigating further. In this first warning issued in six years, pharmaceutical companies are... Read More about Inspector General Issues Fraud Alert Regarding Doctors Paid to Promote Products

Legal term

Search articles and Legalpedia

Subscribe to Newsletter